Alignment Healthcare, Inc.
NASDAQ:ALHC · NASDAQ Global Select
+$0.48 today
Vol 6.64M · Avg 5.33M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-0.4%
avg -52.5%
ROIC
2.5%
avg -25.7%
ROA
-0.1%
avg -18.0%
Analysis
ROIC is currently the strongest return metric at 2.5% versus its period average of -25.7%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
John E. Kao | Founder, Chairman & CEO | $2.78M | — | 64 | $1.61M | 0.78% |
Dawn Christine Maroney | President | $1.74M | — | 58 | $947,313.00 | 0.46% |
Hyong J. Kim | Chief Medical Officer | $1.33M | — | 56 | $331,750.00 | 0.16% |
Christopher J. Joyce | Chief Legal & Administrative Officer | $1.30M | — | 62 | $0.00 | <0.01% |
James Head | Chief Financial Officer | $1.03M | — | 60 | $173,495.00 | 0.08% |
Andreas Wagner | Chief Human Resources Officer | $850,162.00 | — | 56 | $148,628.00 | 0.07% |
Joseph Samuel Konowiecki | Vice Chairman & Executive VP of Corporate Affairs | $100,000.00 | — | 72 | $1.18M | 0.57% |
Randall Fitzpatrick | Senior Vice President of Product | — | — | — | — | — |
Rob Scavo | Chief Information Officer | — | — | 61 | $487,685.00 | 0.24% |
Sergio Zaldivar | Senior Vice President of Business Operations | — | — | — | — | — |
Todd Macaluso | Chief Growth Officer of Health Plan | — | — | — | — | — |
Donald S. Furman | Co-Founder & Chief Clinical Officer | — | — | 75 | $1.53M | 0.74% |
Kerry Matsumoto | Senior Vice President of Clinical Product | — | — | — | — | — |
Shane Hochradel | Chief Operations Officer | — | — | — | $0.00 | <0.01% |
Dan Peterson | President of Arizona Market | — | — | — | — | — |
Rich Powers | Senior Vice President of Business Development | — | — | — | — | — |
David Milligan | Senior Vice President of Sales for California | — | — | — | $173,408.00 | 0.08% |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
1
$197,626.88
Sells
95
$1.15B
Net Sentiment
$1.15B
Net selling
Most Active
KAO JOHN E
27 transactions
1–10 of 96
Analysis
Insiders reported 1 buys worth $197,626.88 and 95 sells worth $1.15B over the last 12 months. That adds up to net selling of $1.15B. KAO JOHN E was the most active insider with 27 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A2 analysts |
| Revenue | N/A | N/A | +23.9% | +33.4% (7yr)3 analysts |
| Net Income | N/A | N/A | N/A | N/A3 analysts |
| EBIT | N/A | N/A | N/A | N/A3 analysts |
Analysis
Recent growth has been strongest in Revenue at +23.9% over three years. Forward estimates point to Revenue at +33.4% (7yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Oscar Health, Inc.
NYSE:OSCR
$7.25B
Apogee Therapeutics, Inc.
NASDAQ:APGE
$5.45B
Mirum Pharmaceuticals, Inc.
NASDAQ:MIRM
$5.29B
Envista Holdings Corp
NYSE:NVST
$4.19B
ICU Medical, Inc.
NASDAQ:ICUI
$3.45B
Dyne Therapeutics, Inc.
NASDAQ:DYN
$3.25B
Privia Health Group, Inc.
NASDAQ:PRVA
$2.97B
Soleno Therapeutics, Inc.
SLNO
$2.76B
Ultragenyx Pharmaceutical Inc.
NASDAQ:RARE
$2.70B
GRAIL, Inc.
NASDAQ:GRAL
$2.68B
Who manages ALHC?
Alignment Healthcare, Inc. (ALHC) lists 17 active executives. The top listed executive is Randall Fitzpatrick, Senior Vice President of Product.
Are ALHC insiders buying or selling?
Recent insider activity shows net selling of $1.69B.
Explore More
Continue the stock analysis
Jump to another research area for this company.